Pharmacological hepatic preconditioning: involvement of 70-kDa heat shock proteins (HSP72 and HSP73) in ischaemic tolerance after intravenous administration of doxorubicin
M. Kume et al., Pharmacological hepatic preconditioning: involvement of 70-kDa heat shock proteins (HSP72 and HSP73) in ischaemic tolerance after intravenous administration of doxorubicin, BR J SURG, 87(9), 2000, pp. 1168-1175
Background: Pharmacological preconditioning may induce a stress response wh
ich protects liver against ischaemia-reperfusion injury (IRI). The aim of t
his study was to determine, in an animal model, whether intravenous adminis
tration of doxorubicin induces heat shock proteins (HSPs) in liver tissue a
nd facilitates liver tolerance to subsequent warm IRI.
Methods: Male Wistar rats were used. Production of HSPs was determined in l
iver tissue sequentially after the injection of doxorubicin 1 mg/kg body-we
ight. Acquisition of tolerance for 30 min warm ischaemia and reperfusion of
the liver was determined in animals pretreated (48 h beforehand) with doxo
rubicin, and in controls. Biochemical liver function and liver adenine nucl
eotide concentration 40 min after reperfusion and survival rate at 7 days a
fter the ischaemic insult were recorded.
Results: Expression of HSP72 and HSP73 in the liver was confirmed 48 h afte
r doxorubicin administration. Biochemical parameters and survival rates wer
e significantly better in pretreated animals than in controls.
Conclusion: These results indicate that doxorubicin has the potential to pr
ovide the liver with tolerance against IRI. A simultaneous increase of both
HSP72 and HSP73 in liver tissue may explain the acquisition of tolerance f
ollowing the administration of doxorubicin.